BBMRI-LPC

Abstract:

Lead by UH-FIMM.

BBMRI-LPC unites the large study sets of the European Biobanking and Biomolecular resources Research Infrastructure (BBMRI) and the International Agency for Research on Cancer (IARC), thus achieving a worldwide unique scale of integration.

Specifically, we aim to:

1. Evaluate/improve the harmonisation of individual data on health, lifestyle and other exposures;
2. Develop/implement harmonised definitions of diseases;
3. Improve biobanking and research technologies and develop innovative solutions facilitating high-quality, fair transnational access to samples and data;
4. Provide free transnational access by users, through study proposals selected by an open, pan-European call;
5. In the framework of these studies, generate and provide access to whole genome sequences, transcriptome, proteome, metabolome and methylome data;
6. Build new public-private partnerships involving large-scale prospective cohorts, and strengthening existing ones, allowing transparent industrial access to academic expertise;
7. Build a network transferring the expertise of established European large-scale biobanks to new biobank initiatives under development in other countries (BBMRI-LPC Forum).

List of Participants

Helsingin Yliopisto (UH-FIMM); Academisch Ziekenhuis Leiden Leid Universitair Medisch Centrum (LUMC); Centre International de Recherche Sur le Cancer (IARC-WHO); Imperial College of Science, Technology and Medicine (ICL); Medizinische Universitat Graz MEDUNI Graz (MUG); Karolinska Institutet(KI); Genome Research Limited (WTSI); Academisch Ziekenhuis Groningen (UMCG); Helmholtz Zentrum Muenchen Deutsches Forschungszentrum fuer Gesundheit un Umwelt GmBh (HMGU); Norges Teknisk Naturvitenskapelige Universitet (NTNU); Tartu Ulikool (UTARTU); Uppsala Universitet (UU); Centre Nacional D’Anàlisi Genòmica Fundacio Centre de Regulacio Genomica (CNAG-CRG); Cambridge Protein Arrays LTD (CPA); Pecsi Tudomanyegyetem University of PECS (UP); The Research Institute of the Mc Gill University Health Centre (RI MUHC); Legal Pathways BV (Legal Pathways); Islensk Erfdagreining EHF (DECODE); Terveyden Ja Hyvinvoinnin Laitos (THL); International Prevention ResearchInstitut IPRI Management (IPRI); Latvijas Biomedicinas Petijumu un Studiju Centrs (LBMC); Sveuciliste U Splitu University of SPLIT (CCGH); Wroclawskie Centrum Badan EIT + Sp. z o.o. (EIT+); Klinikum Rechts der Isar der Technischen Universitat Munchen (TUM-MED); Institut national de la Sante et de lat Recherche Medicale (INSERM); MedLawconsult (Medlaw); Universiteit Maastricht (MU); Nasjonalt Folkehelseinstitutt (NIPH); Statens Serum Institut (SSI), University of Bristol (UBRIS), BBMRI-ERIC, Universita Degli Stufi di Milano Bicocca (UNIMIB)